Over the Counter Medications, Brand Names Beginning with ‘K’

Page 1 of 111 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

K CARE OCEAN MIST (BENZALKONIUM CHLORIDE)

FOR WASHING TO DECREASE BACTERIA ON THE SKIN WARNINGS: FOR EXTERNAL USE ONLY. WHEN USING THIS PRODUCT: AVOID CONTACT WITH EYES. IF CONTACT OCCURS. RINSE THOROUGHLY WITH WATER STOP USING THIS PRODUCT AND ASK DOCTOR IF IRRITATION AND REDNESS DEVELOPS…

THE KROGER COMPANY11 April 2014

K Oxiderm OP Post Procedure Skin Care Bruise (1)

K Oxiderm OP Post Procedure Skin Care Bruise (Magnesium Ascorbyl Phosphate)

For 4~5 days before cosmetic application, apply thinly twice a day, morning and night, after cleansing the skin apply K oxiderm OP cream right after cosmetic application K oxiderm OP cream is recommended for 10 to 15 days as preparatory skin care…

EZEKIELCOSMETIC CO., LTD25 August 2017

K-Mart SmartSense First Aid Contains 101 Pieces (BENZALKONIUM CHLORIDE, LIDOCAINE, WATER, ISOPROPYL ALCOHOL, ASPIRIN)

Warnings: For external use only. Do not use: In eyes, in large quantities, over raw blistered areas, or on deep puncture wounds, animal bites or serious burns, for more than one week Keep out of reach of Children. If ingested, contact a Poison…

K Mart14 June 2010

K-Mart SmartSense First Aid Contains 303 Pieces (BENZALKONIUM CHLORIDE, LIDOCAINE, WATER, ISOTROPYL ALCOHOL, BENZOCAINE, ALCOHOL, ASPIRIN)

Kmart Corporation14 June 2010

K-MEGA Hand Sanitizer (Alcohol)

For the external use only For external use only. Flammable, keep away from fire or flame. When using this product keep out of eyes. If contact with eyes occurs, rinse promptly and…

Soriso17 June 2020

Page 1 of 111 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

FDA Medwatch

Antiseizure Medicines Keppra, Keppra XR, Elepsia XR, Spritam (levetiracetam) and Onfi, Sympazan (clobazam): Drug Safety Communication – FDA Warns of Rare but Serious Drug Reaction
Mon, 27 Nov 2023. The FDA is warning that the antiseizure medicines can cause a rare but serious reaction, called Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), that can be life-threatening if not diagnosed and treated quickly.
BCMA-Directed or CD19-Directed Autologous Chimeric Antigen Receptor (CAR) T cell Immunotherapies: FDA Safety Communication – FDA Investigating Serious Risk of T-cell Malignancy
Mon, 27 Nov 2023. The FDA has received reports of T-cell malignancies, including chimeric antigen receptor CAR-positive lymphoma, in patients who received treatment with BCMA- or CD19-directed autologous CAR T cell immunotherapies.

OTCLabels

Medication Sections

Medication Information by RSS

About

Our database comes directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. OTCLabels.com provides the full over the counter products subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.